COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Fibrogen Inc |
180.01 |
0.03% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
14.31% |
14.29% |
13.89% |
Merck and Co Inc |
63,922.00 |
10.24% |
10.14% |
9.64% |
Pfizer Inc |
62,463.00 |
10.01% |
8.95% |
10.96% |
Sanofi |
49,599.72 |
7.95% |
7.95% |
0.00% |
Eli Lilly And Company |
49,003.20 |
7.85% |
8.31% |
8.35% |
Bristol myers Squibb Company |
47,636.00 |
7.63% |
7.31% |
7.61% |
Novartis Ag |
46,660.00 |
7.48% |
7.48% |
0.00% |
Astrazeneca Plc |
45,811.00 |
7.34% |
7.34% |
0.00% |
Amgen Inc |
33,424.00 |
5.36% |
5.93% |
5.25% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.67% |
4.67% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
4.60% |
4.35% |
4.67% |
Teva Pharmaceutical Industries Limited |
16,617.00 |
2.66% |
2.54% |
2.61% |
Viatris Inc |
14,330.20 |
2.30% |
2.12% |
2.18% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
2.26% |
1.98% |
2.34% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.78% |
1.81% |
1.80% |
Organon and Co |
6,294.00 |
1.01% |
0.99% |
0.98% |
Moderna Inc |
3,177.00 |
0.51% |
0.07% |
0.60% |
Alnylam Pharmaceuticals Inc |
2,348.10 |
0.38% |
0.39% |
0.37% |
Sarepta Therapeutics Inc |
2,233.37 |
0.36% |
0.49% |
0.41% |
Emergent Biosolutions Inc |
965.40 |
0.15% |
0.15% |
0.12% |
Ionis Pharmaceuticals Inc |
941.14 |
0.15% |
0.09% |
0.19% |
Opko Health Inc |
689.41 |
0.11% |
0.10% |
0.11% |
Arvinas Inc |
426.90 |
0.07% |
0.12% |
0.04% |
Innoviva Inc |
408.35 |
0.07% |
0.05% |
0.06% |
Myovant Sciences Ltd |
379.11 |
0.06% |
0.07% |
0.06% |
Mannkind Corporation |
297.60 |
0.05% |
0.05% |
0.05% |
Dynavax Technologies Corporation |
294.62 |
0.05% |
0.04% |
0.04% |
Legend Biotech Corporation |
285.14 |
0.05% |
0.05% |
0.00% |
Arrowhead Pharmaceuticals Inc |
278.34 |
0.04% |
0.35% |
0.00% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Esperion Therapeutics Inc |
259.57 |
0.04% |
0.04% |
0.04% |
Keros Therapeutics Inc |
239.20 |
0.04% |
0.14% |
0.01% |
Puma Biotechnology Inc |
232.71 |
0.04% |
0.03% |
0.04% |
Akebia Therapeutics Inc |
184.91 |
0.03% |
0.04% |
0.03% |
Arcturus Therapeutics Holdings Inc |
143.68 |
0.02% |
0.02% |
0.01% |
Arcus Biosciences Inc |
141.00 |
0.02% |
0.02% |
0.02% |
Bridgebio Pharma Inc |
127.42 |
0.02% |
0.08% |
0.00% |
Xencor Inc |
127.23 |
0.02% |
0.02% |
0.03% |
Siga Technologies Inc |
120.33 |
0.02% |
0.00% |
0.05% |
Anaptysbio inc |
111.87 |
0.02% |
0.02% |
0.03% |
Wave Life Sciences Ltd |
104.94 |
0.02% |
0.01% |
0.05% |
Roivant Sciences Ltd |
97.56 |
0.02% |
0.00% |
0.01% |
Nektar Therapeutics |
87.25 |
0.01% |
0.01% |
0.02% |
Theravance Biopharma inc |
65.27 |
0.01% |
0.01% |
0.01% |
Curevac N v |
60.21 |
0.01% |
0.01% |
0.00% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Journey Medical Corp |
56.24 |
0.01% |
0.01% |
0.01% |
Integrated Biopharma Inc |
53.38 |
0.01% |
0.01% |
0.01% |
Xoma Royalty Corporation |
42.91 |
0.01% |
0.01% |
0.01% |
Tango Therapeutics Inc |
40.99 |
0.01% |
0.00% |
0.00% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Agios Pharmaceuticals Inc |
36.50 |
0.01% |
0.01% |
0.01% |
Cryo cell International Inc |
32.10 |
0.01% |
0.01% |
0.00% |
Elicio Therapeutics Inc |
29.70 |
0.00% |
0.00% |
0.00% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.01% |
0.00% |
Silence Therapeutics Plc |
25.06 |
0.00% |
0.00% |
0.03% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Abcellera Biologics Inc |
23.11 |
0.00% |
0.00% |
0.00% |
Capricor Therapeutics inc |
22.27 |
0.00% |
0.00% |
0.01% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Immunome Inc |
12.51 |
0.00% |
0.00% |
0.00% |
Nuvation Bio Inc |
10.79 |
0.00% |
0.00% |
0.00% |
Fulcrum Therapeutics Inc |
10.72 |
0.00% |
0.00% |
0.00% |
Avidity Biosciences Inc |
9.65 |
0.00% |
0.00% |
0.00% |
Vbi Vaccines Inc |
9.41 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics inc |
9.27 |
0.00% |
0.00% |
0.00% |
Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
Aravive Inc |
7.00 |
0.00% |
0.00% |
0.00% |
Exicure Inc |
6.81 |
0.00% |
0.00% |
0.00% |
Chinook Therapeutics Inc |
5.85 |
0.00% |
0.00% |
0.00% |
Geovax Labs Inc |
5.59 |
0.00% |
0.00% |
0.00% |
Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
Xenetic Biosciences Inc |
2.58 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Ibio inc |
2.11 |
0.00% |
0.00% |
0.00% |
Cocrystal Pharma Inc |
2.01 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
1.41 |
0.00% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Synlogic Inc |
0.71 |
0.00% |
0.00% |
0.00% |
Eterna Therapeutics Inc |
0.58 |
0.00% |
0.00% |
0.00% |
Imunon Inc |
0.50 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Actavia Life Sciences Inc |
0.12 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Benitec Biopharma Inc |
0.06 |
0.00% |
0.00% |
0.00% |
Serina Therapeutics Inc |
0.06 |
0.00% |
0.00% |
0.00% |
Altimmune inc |
0.02 |
0.00% |
0.00% |
0.00% |
Atossa Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Palvella Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Transcode Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Pyxis Oncology Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atreca inc |
0.00 |
0.00% |
0.00% |
0.00% |
Unity Biotechnology Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Globestar Therapeutics Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Alaunos Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vincerx Pharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moleculin Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Applied Molecular Transport Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Oncorus Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Evelo Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Centessa Pharmaceuticals Plc |
0.00 |
0.00% |
0.01% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Cohbar Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vaxxinity Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nanoviricides inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Indaptus Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Pardes Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Briacell Therapeutics Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Abivax Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Alx Oncology Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Beigene Ltd |
0.00 |
0.00% |
0.73% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Precigen Inc |
-2.19 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
624,137.35 |
100% |
153,182.25 |
100% |
FGEN's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
FGEN's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
Note: Market share is calculated based on total revenue. To get a more accurate picture of Fibrogen Inc's market divisions, geographic dispersion, segments, products, and services, visit
Fibrogen Inc's Business Segment.
The list includes publicly traded companies only. More information about the sources of this report can be found
here.